We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Investor Sues Drugmaker Over Lack Of Control Group In Trials

Law360 (January 29, 2019, 2:09 PM EST) -- An investor in drugmaker Tyme Technologies Inc. filed suit against the biotechnology company in New York federal court on Monday, claiming its failure to include a control group in clinical trials...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

January 28, 2019

Law Firms

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.